The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDestiny Pharma. Share News (DEST)

Share Price Information for Destiny Pharma. (DEST)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 15.75
Bid: 15.50
Ask: 16.00
Change: -0.50 (-3.08%)
Spread: 0.50 (3.226%)
Open: 16.25
High: 16.25
Low: 15.70
Prev. Close: 16.25
DEST Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK shareholder meetings calendar - next 7 days

Thu, 27th May 2021 16:06

Friday 28 May 
AG Barr PLCAGM
Agronomics LtdGM re fundraising
AIQ LtdAGM
Aseana Properties LtdGM re future of company
Ebiquity PLCAGM
HSBC Holdings PLCAGM
Minoan Group PLCAGM
Real Estate Investors PLCAGM
Reckitt Benckiser Group PLCAGM
Rotala PLCAGM
Tekcapital PLCAGM
Wameja LtdAGM
Monday 31 May 
no events scheduled 
Tuesday 1 June 
Churchill China PLCAGM
North American Income Trust PLCAGM
Wednesday 2 June 
Arrow Global Group PLCAGM
Everyman Media Group PLCAGM
Futura Medical PLCGM re fundraise
Gaming Realms PLCAGM
Gem Diamonds LtdAGM
GYG PLCAGM
Jersey Oil & Gas PLCAGM
Manx Financial Group PLCAGM
Pennant International Group PLCAGM
Surface Transforms PLCAGM
Tern PLCGM re authority to issue shares
Thursday 3 June 
Camellia PLCAGM
CentralNic Group PLCAGM
Checkit PLCAGM
Destiny Pharma PLCAGM
Flowtech Fluidpower PLCAGM
i3 Energy PLCGM re share capital reduction
Informa PLCAGM
Kazera Global PLCAGM
Menhaden PLCAGM
Michelmersh Brick Holdings PLCAGM
NetScientific PLCAGM
PageGroup PLCAGM
Pebble Group PLCAGM
Tissue Regenix Group PLCAGM
  
Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
1 Nov 2018 13:09

Destiny Pharma Biofilm Project With Southampton Uni Secures Funding

LONDON (Alliance News) - Destiny Pharma PLC said Thursday it had been jointly granted funding with the University of Southampton to examine the use of its technology to eradicate clinical caused a

Read more
25 Oct 2018 11:23

Destiny Pharma Hires Creabilis's Shaun Claydon As New Finance Head

LONDON (Alliance News) - Destiny Pharma PLC said on Thursday it has appointed Shaun Claydon as its new finance chief after the departure of Chief Financial Officer Simon Sacerdoti.Claydon,

Read more
19 Oct 2018 14:54

Destiny Pharma helps with new bioindustry association videos

(Sharecast News) - Clinical-stage biotechnology company Destiny Pharma noted the launch of a series of videos and explainer documents from the UK BioIndustry Association (BIA) celebrating UK bioscience and revealing the research and development taking place in biotech companies around the UK on Friday.

Read more
26 Sep 2018 12:39

Destiny Pharma Loss More Than Doubles On Administrative Expenses

LONDON (Alliance News) - Destiny Pharma PLC on Wednesday reported a substantial widening of its loss in the first half of the year due to administrative expenses.The clinical stage company

Read more
6 Sep 2018 13:24

Destiny Pharma Chairman Nigel Rudd To Step Down In December

LONDON (Alliance News) - Destiny Pharma PLC said Thursday that Chairman Nigel Rudd stepped down from the company in December after eight years.Non-Executive Director Nick Rodgers will Rudd

Read more
6 Sep 2018 10:32

Chairman of Destiny calling time after 15 years with pharma firm

(Sharecast News) - Clinical stage biotechnology firm Destiny Pharma revealed on Thursday that long-time chairman Nigel Rudd was stepping down from the board on 31 December after eight years.

Read more
26 Jul 2018 13:49

Destiny Pharma Receives Positive Results From Skin Irritation Study

LONDON (Alliance News) - Destiny Pharma PLC said Thursday that it received positive data from the Phase I of its XF-73 skin irritation study.The clinical stage biotechnology company said is

Read more
21 Jun 2018 10:25

Destiny Pharma Appoints SEHTA Chairman Nick Rodgers As Non-Executive

LONDON (Alliance News) - Anti-microbial resistance-focused biotechnology developer Destiny Pharma PLC said Thursday it has appointed Nick Rodgers as an independent non-executive director with is a

Read more
30 May 2018 13:00

Destiny Pharma Creates Independent Scientific Advisory Board

LONDON (Alliance News) - Destiny Pharma PLC said Wednesday it has formed a scientific advisory board to provide "expert, independent analysis" of the company's research and clinical

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.